Pre-Market | Federal Reserve Pick Looms as Markets Surge and Tech Stocks Tumble

Generated by AI AgentAinvest Market Brief
Monday, Aug 4, 2025 8:05 am ET1min read
Aime RobotAime Summary

- U.S. President Trump announced a candidate for the vacant Federal Reserve Board seat, signaling potential monetary policy shifts amid pre-market stock index gains.

- Market reactions included Spotify (+3.68%) from price hikes, UBS (+2.62%) on strong earnings, and Replimune (-34.87%) after FDA rejected its melanoma therapy due to flawed trial design.

- Tesla granted 96M shares to Elon Musk at $23.34/share and reported 67,886 China wholesale sales, while Alphabet's VC arm negotiated a $90B+ investment in AI firm Vast Data with Nvidia.

- Ezgo Technologies (-31.37%) and Stryker (-2.99%) declined despite revenue beats, reflecting investor skepticism over growth stability and earnings performance.

4 Aug., U.S. President announced plans to name a candidate for the vacant Federal Reserve governor position in the coming days, highlighting potential monetary policy implications. Meanwhile, DOW FUTURES up 0.40% in pre-market, NASDAQ FUTURES up 0.72% in pre-market, S&P FUTURES up 0.50% in pre-market.

In pre-market trading,

saw a rise of 3.68% following the announcement of an increase in subscription prices. also experienced a positive start to the day, rising 2.62% as better-than-expected earnings were driven by market volatility boosting trading activity. Meanwhile, dropped 2.99% despite beating revenue expectations, as earnings per share missed analyst forecasts. shares fell 1.03% in pre-market trading.

Replimune Group's stock plummeted 34.87% in pre-market trading after the FDA rejected its melanoma therapy application. The rejection was due to inadequate trial design and patient heterogeneity, which raised concerns about the efficacy and safety of the treatment. Meanwhile,

saw its shares drop 31.37% in pre-market trading. Investors expressed skepticism over the company's weak revenue growth and unstable medium-term performance, leading to a significant sell-off.

approved granting 96 million shares to Elon Musk at $23.34 per share and awarded a temporary CEO prize for 2025, while reporting wholesale sales in China reaching 67,886 units in July. Alphabet's venture capital arm is negotiating with to invest in AI infrastructure provider Vast Data, potentially valuing the startup at $90 billion. President Trump stated he will announce a candidate for the vacant Federal Reserve Board seat in coming days.

Comments



Add a public comment...
No comments

No comments yet